Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Novartis to Comarket Lucentis with Alcon Japan
February 9, 2009
- Updated GL for Colon Cancer to Recommend Bevacizumab, Cetuximab
February 9, 2009
- GSK's 1,200 MRs Start Detailing Adoair for COPD
February 9, 2009
- SELF-MEDICATION NEWS IN BRIEF
February 9, 2009
- 3-Qtr Business Results: 1
February 9, 2009
- Korosho to Study Efficacy of Tamiflu against Resistant Strains
February 9, 2009
- BUSINESS NEWS IN BRIEF
February 9, 2009
- SEMINAR
February 9, 2009
- NHI Societies Asked to More Actively Promote Use of Generics
February 9, 2009
- Takeda Obtains Approval for Lansoprazole's Successor in US
February 9, 2009
- Group of Health Insurance Societies to Promote Use of Generics
February 9, 2009
- Risperidone, Olanzapine, Quetiapine Likely to Be Related to Diabetes: AERS DB Analysis
February 9, 2009
- Astellas Proposes Acquisition to CV Therapeutics
February 2, 2009
- JIRA to Demand Digital X-Ray Imaging Fee
February 2, 2009
- Financial Crisis Offers Opportunity for Cash-Rich Biopharma Companies: BCG
February 2, 2009
- MEDICAL DEVICE NEWS IN BRIEF
February 2, 2009
- Hisamitsu to Comarket Fosamac with Banyu
February 2, 2009
- SELF-MEDICATION NEWS IN BRIEF
February 2, 2009
- Wholesalers Have Been Driven Over the Edge: Mr Kimura
February 2, 2009
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 2, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…